Basant M Saleh
Zagazig University, Egypt
Posters & Accepted Abstracts: J Chem Sci
We previously identified one large molecular structure targeting the HIV-1 gp41, 2-Aryl 5-(4-Oxo-3-phenethyl-2- thioxothiazolidinylidenemethyl) furan, which acts as lead compound for our novel synthetized drugs. On the basis of molecular docking analysis, we designed a series of -5-benzylidene-3-phenethylimidazolidine-2,4-dione. Novel thiazolidinedione derivatives were synthesized starting from hydantoin and thiohydantoin. 5-benzylidene-3-phenethylimidazolidine-2,4-diones were synthetized by alkylation followed by a Knoevenagel condensation and tested for their anti-HIV-1 activity and cytotoxicity on MT-2 cells. The synthesized compounds were characterized by 1H NMR, 13C NMR, mass spectroscopy, high resolution mass spectroscopy, IR and physical data.
Chemical Sciences Journal received 912 citations as per Google Scholar report